Literature DB >> 20332272

Custodianship as an ethical framework for biospecimen-based research.

Rihab Yassin1, Nicole Lockhart, Mariana González del Riego, Karen Pitt, Jeffrey W Thomas, Linda Weiss, Carolyn Compton.   

Abstract

Human biological specimens (biospecimens) are increasingly important for research that aims to advance human health. Yet, despite significant proliferation in specimen-based research and discoveries during the past decade, research remains challenged by the inequitable access to high-quality biospecimens that are collected under rigorous ethical standards. This is primarily caused by the complex level of control and ownership exerted by the myriad of stakeholders involved in the biospecimen research process. This article discusses the ethical model of custodianship as a framework for biospecimen-based research to promote fair research access and resolve issues of control and potential conflicts between biobanks, investigators, human research participants (human subjects), and sponsors. Custodianship is the caretaking obligation for biospecimens from initial collection to final dissemination of research findings. It endorses key practices and operating principles for responsible oversight of biospecimens collected for research. Embracing the custodial model would ensure transparency in research, fairness to human research participants, and shared accountability among all stakeholders involved in biospecimen-based research.

Entities:  

Mesh:

Year:  2010        PMID: 20332272      PMCID: PMC2858050          DOI: 10.1158/1055-9965.EPI-10-0029

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  Body of research--ownership and use of human tissue.

Authors:  R Alta Charo
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

2.  Biospecimen "ownership": counterpoint.

Authors:  Lynn G Dressler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

3.  Key elements of access policies for biorepositories associated with population science research.

Authors:  Shannon M Lemrow; Graham A Colditz; Jimmie B Vaught; Patricia Hartge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

4.  Institutional policy on financial conflict of interest: objectivity in research.

Authors:  Moshe Shalev
Journal:  Lab Anim (NY)       Date:  2003-04       Impact factor: 12.625

5.  Use of human tissues in research: clarifying clinician and researcher roles and information flows.

Authors:  J F Merz; P Sankar; S E Taube; V Livolsi
Journal:  J Investig Med       Date:  1997-06       Impact factor: 2.895

Review 6.  An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research.

Authors:  Andrew D Boyd; Charlie Hosner; Dale A Hunscher; Brian D Athey; Daniel J Clauw; Lee A Green
Journal:  Int J Med Inform       Date:  2006-11-01       Impact factor: 4.046

7.  A biobank management model applicable to biomedical research.

Authors:  Christiane Auray-Blais; Johane Patenaude
Journal:  BMC Med Ethics       Date:  2006-04-06       Impact factor: 2.652

  7 in total
  21 in total

1.  Ultrasound-guided procedures in medical education: a fresh look at cadavers.

Authors:  Riley Hoyer; Russel Means; Jeffrey Robertson; Douglas Rappaport; Charles Schmier; Travis Jones; Lori Ann Stolz; Stephen Jerome Kaplan; William Joaquin Adamas-Rappaport; Richard Amini
Journal:  Intern Emerg Med       Date:  2015-08-15       Impact factor: 3.397

Review 2.  Return of individual research results and incidental findings: facing the challenges of translational science.

Authors:  Susan M Wolf
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

Review 3.  Biobanking residual tissues.

Authors:  Peter H J Riegman; Evert-Ben van Veen
Journal:  Hum Genet       Date:  2011-08-04       Impact factor: 4.132

4.  Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional study.

Authors:  Holger Langhof; Hannes Kahrass; Sören Sievers; Daniel Strech
Journal:  Eur J Hum Genet       Date:  2016-12-21       Impact factor: 4.246

5.  Fundamental Considerations for Biobank Legacy Planning.

Authors:  Lise Anne Marie Matzke; Benjamin Fombonne; Peter Hamilton Watson; Helen Marie Moore
Journal:  Biopreserv Biobank       Date:  2016-02-18       Impact factor: 2.300

6.  Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report.

Authors:  Meira Epplein; Roberd M Bostick; Lina Mu; Shuji Ogino; Dejana Braithwaite; Peter A Kanetsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

7.  Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.

Authors:  Holger Langhof; Hannes Kahrass; Thomas Illig; Roland Jahns; Daniel Strech
Journal:  Eur J Hum Genet       Date:  2018-08-08       Impact factor: 4.246

8.  Enhancing Biospecimen Knowledge Among Health Care Providers and Representatives From Community Organizations.

Authors:  Heidi M Tham; Sarah Hohl; Wade Copeland; Katherine J Briant; Leticia Márquez-Magaña; Beti Thompson
Journal:  Health Promot Pract       Date:  2016-04-26

Review 9.  The evolution of biobanking best practices.

Authors:  Jim Vaught; Nicole C Lockhart
Journal:  Clin Chim Acta       Date:  2012-05-03       Impact factor: 3.786

10.  Managing incidental findings and research results in genomic research involving biobanks and archived data sets.

Authors:  Susan M Wolf; Brittney N Crock; Brian Van Ness; Frances Lawrenz; Jeffrey P Kahn; Laura M Beskow; Mildred K Cho; Michael F Christman; Robert C Green; Ralph Hall; Judy Illes; Moira Keane; Bartha M Knoppers; Barbara A Koenig; Isaac S Kohane; Bonnie Leroy; Karen J Maschke; William McGeveran; Pilar Ossorio; Lisa S Parker; Gloria M Petersen; Henry S Richardson; Joan A Scott; Sharon F Terry; Benjamin S Wilfond; Wendy A Wolf
Journal:  Genet Med       Date:  2012-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.